<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>The comparison of clinical management and outcomes between patients hospitalized with FluA-p and FluB-p in China, 2013–2019</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Variable</th>
    <th>Total (
     <italic>n</italic> = 1079)
    </th>
    <th>FluA-p (
     <italic>n</italic> = 693)
    </th>
    <th>FluB-p (
     <italic>n</italic> = 386)
    </th>
    <th>
     <italic>P</italic>-value
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Early NAI therapy (
     <italic>n</italic>, %)
    </td>
    <td>385 (35.7)</td>
    <td>232 (33.5)</td>
    <td>153 (39.6)</td>
    <td>
     <bold>0.043</bold>
    </td>
   </tr>
   <tr>
    <td>Systemic corticosteroid use during hospitalization (
     <italic>n</italic>, %)
    </td>
    <td>262 (24.3)</td>
    <td>132 (19.0)</td>
    <td>130 (33.7)</td>
    <td>
     <bold>&lt;  0.001</bold>
    </td>
   </tr>
   <tr>
    <td colspan="5">Complications during hospitalization</td>
   </tr>
   <tr>
    <td> Respiratory failure</td>
    <td>249 (23.1)</td>
    <td>167 (24.1)</td>
    <td>82 (21.2)</td>
    <td>0.286</td>
   </tr>
   <tr>
    <td> Heart failure</td>
    <td>265 (24.6)</td>
    <td>147 (21.2)</td>
    <td>118 (30.6)</td>
    <td>
     <bold>0.001</bold>
    </td>
   </tr>
   <tr>
    <td> Septic shock</td>
    <td>53 (4.9)</td>
    <td>36 (5.2)</td>
    <td>17 (4.4)</td>
    <td>0.565</td>
   </tr>
   <tr>
    <td> Acute renal failure</td>
    <td>39 (3.6)</td>
    <td>27 (3.9)</td>
    <td>12 (3.1)</td>
    <td>0.507</td>
   </tr>
   <tr>
    <td> Bloodstream infection</td>
    <td>9 (0.8)</td>
    <td>8 (1.2)</td>
    <td>1 (0.3)</td>
    <td>0.121</td>
   </tr>
   <tr>
    <td>Noninvasive ventilation (
     <italic>n</italic>, %)
    </td>
    <td>279 (25.9)</td>
    <td>159 (22.9)</td>
    <td>120 (31.1)</td>
    <td>
     <bold>0.003</bold>
    </td>
   </tr>
   <tr>
    <td>Invasive ventilation (
     <italic>n</italic>, %)
    </td>
    <td>193 (17.9)</td>
    <td>158 (22.8)</td>
    <td>35 (9.1)</td>
    <td>
     <bold>&lt;  0.001</bold>
    </td>
   </tr>
   <tr>
    <td>Vasopressor use (
     <italic>n</italic>, %)
    </td>
    <td>40 (3.7)</td>
    <td>27 (3.9)</td>
    <td>13 (3.4)</td>
    <td>0.660</td>
   </tr>
   <tr>
    <td>Admittance to ICU (
     <italic>n</italic>, %)
    </td>
    <td>242 (22.4)</td>
    <td>176 (25.4)</td>
    <td>66 (17.1)</td>
    <td>
     <bold>0.001</bold>
    </td>
   </tr>
   <tr>
    <td>
     <p>Length of stay in hospital</p>
     <p>(days, median, IQR)</p>
    </td>
    <td>10.0 (8.0–14.0)</td>
    <td>12.0 (7.0–14.5)</td>
    <td>10.0 (8.0–17.0)</td>
    <td>
     <bold>&lt;  0.001</bold>
    </td>
   </tr>
   <tr>
    <td>30-day mortality (
     <italic>n</italic>, %)
    </td>
    <td>208 (19.3)</td>
    <td>136 (19.6)</td>
    <td>72 (18.7)</td>
    <td>0.698</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>NAI</italic> neuraminidase inhibitor, 
   <italic>ICU</italic> intensive care unit; IQR: Interquartile range
  </p>
 </table-wrap-foot>
</table-wrap>
